Abstract

Aims: This study examined the comparative study of otitis media and its antibiotics susceptibility pattern in a cohort of HIV positive and negative patients.
 Study Design: A survey and laboratory analytical method was employed in the study. While a survey research design was used to sample a total of 110 patients out of a total population of 561,066 living in the study area. Laboratory analyses of the samples collected from the patients were used to analyze the data collected.
 Methodology: A total of 110 ear swabs were collected, 60 from HIV positive subjects and 50 from HIV negatives subjects with otitis media.
 Results: From the analysis of the data collected, results showed that 52 (86.7) samples from HIV positive patients and 44 (88%) samples from HIV negative patients yielded bacteria growth. The most predominant isolates from middle ear of HIV positive was Staphylococcus aureus, with total occurrence of 22(42.4%), followed by Pseudomonas aeruginosa, Streptococcus pneumonia, Klebsiella pneumoniae and Escherichia coli with occurrence of 12(23%), 7(13.5%), 6(11.5%), 5(9.6%) respectively. The most predominant from HIV negative was Staphylococcus aureus, followed by Streptococcus pneumonia, Pseudomonas aeruginosa, Klebsiella pneumoniae and Streptococcus pyogenes with occurrence of 16(36.4%), 10(22.7%), 8(18.2%), 6(13.6%), and 4(9.1%) respectively. The result of their antibiotics susceptibility test showed that all the bacteria isolates from both subjects were fully sensitive to fluoroquinolones, while a high level of resistance was seen with the use co-trimoxazole in HIV-positive subjects.
 Conclusion: Bacteria isolates from HIV positive patients were highly resistant to co-trimoxazole as compared to isolates from HIV negative patients that were sensitive to co-trimoxazole. It was also noted in the result that the sensitivity pattern of otitis media to antibiotics differs from HIV positive and HIV negative patients, thus requiring different management approaches.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call